(61)Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. Basaco Bernabeu T, Mansi R, Del Pozzo L, Zanger S, et al. J Nucl Med 2024 Jul 18:jnumed.123.267126. doi: 10.2967/jnumed.123.267126.

Read + Share

Amedeo Smart

Independent Medical Education

Basaco Bernabeu T, Mansi R, Del Pozzo L, Zanger S, et al. (61)Cu-PSMA-Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging. J Nucl Med 2024 Jul 18:jnumed.123.267126. doi: 10.2967/jnumed.123.267126.
PMID: 39025646